z-logo
open-access-imgOpen Access
Nucleobase Derivatives as Building Blocks to Form Ru(II)-Based Complexes with High Cytotoxicity
Author(s) -
Diogo E. L. Carvalho,
Katia M. Oliveira,
Larissa M. Bomfim,
Milena Botelho Pereira Soares,
Daniel P. Bezerra,
Alzir A. Batista,
Rodrigo S. Corrêa
Publication year - 2020
Publication title -
acs omega
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.779
H-Index - 40
ISSN - 2470-1343
DOI - 10.1021/acsomega.9b01921
Subject(s) - chemistry , ruthenium , cytotoxicity , nucleobase , titration , apoptosis , thiouracil , stereochemistry , medicinal chemistry , biomolecule , dna , biochemistry , organic chemistry , biology , in vitro , catalysis , thyroid , endocrinology
Two new Ru(II)-based complexes containing 2-thiouracil derivatives, known as 2-thiouracil (2TU) and 6-methyl-2-thiouracil (6m2TU), were synthesized using cis,trans- [RuCl 2 (PPh 3 ) 2 (bipy)] as a precursor. The obtained compounds with a general formula trans- [Ru(2TU)(PPh 3 ) 2 (bipy)]PF 6 ( 1 ) and trans- [Ru(6m2TU)(PPh 3 ) 2 (bipy)]PF 6 ( 2 ) were characterized by analytical techniques such as NMR, UV-vis, and IR spectroscopies, elementary analysis, mass spectrometry, and single-crystal X-ray diffraction. Moreover, the investigation of the complexes-DNA interaction were carried out using spectrophotometric titrations and showed that the complexes present a weak interaction with this biomolecule. The compounds were evaluated against HL-60, K-562, HepG2, and B16-F10 cancer cells and against noncancer cells (PBMCs). The results of the biological assay revealed that complex 2 is more promising than complex 1 . Finally, the present study suggests that complexes 1 and 2 causes cell death by apoptosis, significantly increasing the percentage of apoptotic HL-60 cells, in which the compounds altered the cell cycle, reducing the cells in G 1 /G 0 , G 2 /M, and S phases.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom